Clinical effects of intermittent pneumatic compression

Momot A.P.; Lebedeva E.I.; Nikolaeva M.G.; Fadeeva N.I.; Kovalev M.V.

doi:https://doi.org/10.17116/repro20192504135

Close metadata

Recommended articles:

Epigenetic regulation in the placenta in case of impaired trophoblast invasion (a review). Russian Journal of Human Reproduction. 2024;(6):45-54

Study of opinions of medical students on medical prevention issues. Russian Journal of Preventive Medicine. 2024;(12):69-74

Assessment of risk of developing fractures and sarcopenia and quality of life of patients with chronic kidney disease at the outpatient stage. Russian Journal of Preventive Medicine. 2024;(12):88-91

Gastric cancer: incidence, risk factors, screening. Russian Journal of Preventive Medicine. 2024;(12):135-139

Peculiarities of placental microRNA expression in patients with preeclampsia and fetal growth restriction. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):14-25

On molecular genetic predictors of preeclampsia. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):26-34

Influence of intermittent pneumatic compression on microvasculature condition in lymphedema. Prospective randomized clinical trial. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):48-53

Positive Predictive Value of the Wells Score in Diagnosis of Deep Vein Thrombosis: Results of Bayesian Analysis. Journal of Venous Disorders. 2024;(4):274-282

The relationship of diet and nutrition with the frequency of migraine attacks. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):30-35

Prevention of periodontal inflammation in microgravity modeling. Stomatology. 2024;(6-2):23-28

Abstract:

The review discusses the range of intermittent pneumatic compression (IPC) effects in clinical practice. The importance of IPC for the correction of pathological conditions accompanied by hypofibrinolysis, including during pregnancy complications, as well as during ART programms.

Keywords:

intermittent pneumatic compression

fibrinolysis

prophylaxis

venous thromboembolism

early pregnancy loss

preeclampsia

Authors:

Momot A.P.

Altai Branch of the FSBI «National Research Center for Hematology», Barnaul, Russia

Lebedeva E.I.

Altai State Medical University, Ministry of Health of the Russia, Barnaul, Russia

Nikolaeva M.G.

Obstetrics and Gynecology Department with the course of Supplementary Vocational Education in FSBEI of Higher Education «Altai State Medical University» Barnaul, Russia

Fadeeva N.I.

Department of Obstetrics and Gynecology with Course of Additional Professional Education, Altai State Medical University, Ministry of Health of Russia, Barnaul, Russia

Kovalev M.V.

Kafedra khirurgii Instituta poslediplomnogo meditsinskogo obrazovaniia Voronezhskoĭ gosudarstvennoĭ meditsinskoĭ akademii im. N.N. Burdenko, Tsentral'naia gorodskaia klinicheskaia bol'nitsa, Lipetsk

Close metadata

References:

Clanny WR. Apparatus for removing the pressure of the atmosphere. Dr. Clanny’s mode of removing atmospheric pressure from the body. Sunderland; 1835: 804-805.
Herrmann LG, Reid MR. Treatment of peripheral obliterative arterial diseases by rhythmic alteration of environmental pressure. Archives of Surgery. 1934;29(5):697-704.
Sabri S, Roberts VC, Cotton LT. Prevention of early postoperative deep vein thrombosis by intermittent compression of the leg during surgery. British Medical Journal. 1971;4:394-396.
Roberts VC, Cotton LT. Prevention of postoperative deep vein thrombosis in patients with malignant disease. British Medical Journal. 1974;1:358-360.
Browse NL, Negus D. Prevention of postoperative leg vein thrombosis by electrical muscle stimulation: an evaluation with I-labelled fibrinogen. British Medical Journal. 1970;3:615-618.
Shvalb PG, Kalinin RE, Pshennikov AS, Suchkov IA. The effect of intermittent pneumatic compression on nitric oxide production as the main marker of endothelial dysfunction in patients with obliterating atherosclerosis of the lower extremities arteries. Novosti chirurgii. 2011;19(3):77-81. (In Russ.)
De Haro J, Acin F, Florez A, Bleda S, Fernandez JL. A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudication. Journal of Vascular Surgery. 2010;51(4):857-862. https://doi.org/10.1016/j.jvs.2009.10.116
Manukhina EB, Malyshev IYu. Role of nitric oxide in the development and prevention of endothelial dysfunction. Vestnik VGMU. 2003;2:5-17. (In Russ.)
Andronov EV, Kirichuk VF, Ivanov AN, Mamontova NV. The Role of nitric oxide in the regulation of microcirculatory hemostatic system (literature review). Saratovskiy Nauchno-Meditsinskiy Zhurnal. 2007;3(17):39-44. (In Russ.)
Aminbakhsh A, Mancini GBJ. Chronic antioxidant use and changes in endothelial dysfunction: a review of clinical investigations. Canadian Journal of Cardiology. 1999;15(8):895-903.
Arnal JF, Dinh-Xuan AT, Pueyo M, Darblade B, Rami J. Endothelium-derived nitric oxide and vascular physiology. Cellular and Molecular Life Sciences. 1999;55(8-9):1078-1087.
Behrendt D, Ganz P. Endothelial function: from vascular biology to clinical applications. American Journal of Cardiology. 2002;90:40-48.
Mattson DL, Maeda CY, Bachman TD. Inducible nitric oxide synthase and blood pressure. Hypertension. 1998;31:15-20.
Credeur DP, Vana LM, Kelley ET, Stoner L, Dolbow DR. Effects of Intermittent Pneumatic Compression on Leg Vascular Function in People with Spinal Cord Injury: A Pilot Study. Journal of Spinal Cord Medicine. 2017;3:1-9. https://doi.org/10.1080/10790268.2017.1360557
Calver A, Collier J, Vallance P. Nitric oxide and cardiovascular control. Experimental Physiology. 1993;78(3):303-326.
Stasch J, Schmidt P, Alonso-Alija C, Apeler H, Dembowsky K, Haerter M, Heil M, Minuth T, Perzborn E, Pleiss U, Schramm M, Schroeder W, Schröder H, Stahl E, Steinke W, Wunder F. NO and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. British Journal of Pharmacology. 2002;136(5):773-783.
Barkagan ZS, Momot AP. Diagnostika i kontroliruemaya terapiya narushenij gemostaza. Izdanie 3-e. M.: N’yudiamed; 2008. (In Russ.)
Choi JW, Pai SH. Tissue plasminogen activator levels change with plasma fibrinogen con-centrations during pregnancy. Annals of Hematology. 2002;81(11):611-615.
Williamson TH, Rumley A, Lowe GD. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. British Journal of Ophthalmology. 1996;80(3):203-208.
Al-Horani RA. Serpin regulation of fibrinolytic system: implications for therapeutic applications in cardiovascular diseases. Cardiovascular and Hematological Agents in Medicinal Chemistry. 2014;12(2):91-125.
Momot AP, Kudinova IYu, Elykomov VA, Semenova NA, Momot DA, Belozerov DE. The role of blood fibrinolytic activity in the prevention of thrombosis during normal pregnancy. Doctor.ru. Hematologiya. 2016;5(122):21-28. (In Russ.) https://doi.org/10/18411/d-2016-059
Momot AP, Nikolaeva MG, Serdyuk GV, Elykomov VA, Mamaev AN. Methodical recommendations (project). Assessment of the hemostasis system in physiological pregnancy. Vestnik Akushera-Ginekologa. 2018;2(3):1-36. (In Russ.)
Romanova ML. Influence of ginkor fort angioprotector on the content of tissue plasminogen activator (t-PA) and its inhibitor (PAI-I) in women with varicose pelvic disease. Regionarnoye krovoobrascheniye i mikrotsyrkulyatsiya. 2004;4(12):92-94. (In Russ.)
Meltzer ME, Lisman T, de Groot PG, Meijers JC, le Cessie S, Doggen CJ, Rosendaal FR. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood. 2010;116(1):113-121.
Comerota AJ, Chouhan V, Harada RN, Sun L, Hosking J, Veermansunemi R. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Annals of Surgery. 1997;226:306-313.
Christen Y, Wütschert R, Weimer D, de Moerloose P, Kruithof EK, Bounameaux H. Effects of intermittent pneumatic compression on venous haemodynamics and fibrinolytic activity. Blood Coagulation and Fibrinolysis. 1997;8(3):185-190.
Reddick KL, Smrtka MP, Grotegut CA, James AH, Brancazio LR, Swamy GK. The Effects of Intermittent Pneumatic Compression during Cesarean Delivery on Fibrinolysis. American Journal of Perinatology. 2014;31(9):735-740. https://doi.org/10.1055/s-0033-1359720
Arabi YM, Al-Hameed F, Burns KEA, Mehta S, Alsolamy SJ, Alshahrani MS, Mandourah Y, Almekhlafi GA, Almaani M, Al Bshabshe A, Finfer S, Arshad Z, Khalid I, Mehta Y, Gaur A, Hawa H, Buscher H, Lababidi H, Al Aithan A, Abdukahil SAI, Jose J, Afesh LY, Al-Dawood A; Saudi Critical Care Trials Group. Critical Care Trials Group. Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis. New England Journal of Medicine. 2019;380:1305-1315. https://doi.org/10.1056/NEJMoa1816150
Pandolfi M, Robertson B, Isacson S, Nilsson IM. Fibrinolytic activity of human veins in arms and legs. Thrombosis et Diathesis Haemorrhagica. 1968;20(1):247-255.
Salzman EW, McManama GP, Shapiro AH. Effect of optimization of hemodynamics on fibrinolytie activity and antithrombotic efficacy of external pneumatic calf compression. Annals of Surgery. 1987;206:636-641.
Zaleska MT, Olszewski WL. The effectiveness of intermittent pneumatic compression in therapy of lymphedema of lower limbs: methods of evaluation and results. Lymphatic Research and Biology. 2019;17(1). https://doi.org/10.1089/lrb.2018.0005
Karafa M, Karafova A, Szuba A. The effect of different compression pressure in therapy of secondary upper extremity lymphedema in women after breast cancer surgery. Lymphology. 2018;51(1):28-37.
Feldman JL, Stout NL, Wanchai A, Stewart BR, Cormier JN, Armer JM. Intermittent pneumatic compression therapy: a systematic review. Lymphology. 2012;45(1):13-25.
Prevention and treatment of venous thromboembolism: international consensus statement (guidelines according to scientific evidence). Cardiovascular Disease Educational and Research Trust; European Venous Forum; North American Thrombosis Forum; International Union of Angiology; Union Internationale du Phlebologie. Clinical and Applied Thrombosis/Hemostasis. 2013;19(2):116-118. https://doi.org/10.1177/1076029612474840
Lauvrak V, Hafstad E, Fure B. Intermittent pneumatic compression to prevent venous thromboembolism in hospitalized patients: Systematic Scoping Review. Folkehelseinstituttet. 2016;24.
CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet. 2013;382:516-524.
Guidelines for the Early Management of Patients With Acute Ischemic Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Available at: https://clck.yandex.ru/redir/nWO_r1F33ck?data Accessed May 25, 2019.
Seeho SK, Nippita TA, Roberts CL, Morris JM, Nassar N. Venous thromboembolism prophylaxis during and following caesarean section: a survey of clinical practice. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2016;56(1):54-59. https://doi.org/10.1111/ajo.12393
Profilaktika venoznyh tromboembolicheskih oslozhnenij v akusherstve i ginekologii. Klinicheskie rekomendacii (protokol lecheniya). Pis’mo Ministerstva zdravoohraneniya Rossijskoj Federacii ot 27 maya 2014 g No. 15-4/10/2-3792. (In Russ.)
Heapy AM, Hoffman MD, Verhagen HH, Thompson SW, Dhamija P, Sandford FJ, Cooper MC. A randomized controlled trial of manual therapy and pneumatic compression for recovery from prolonged running — an extended study. Research in Sports Medicine. 2018;26(3):354-364. https://doi.org/10.1080/15438627.2018.1447469
Kakkos SK, Caprini JA, Geroulakos G. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism. The Cochrane Database of Systematic Reviews. 2016;9:CD005258. https://doi.org/10.1002/14651858.CD005258.pub3
Vignon P, Dequin PF, Renault A. Intermittent pneumatic compression to prevent venous thromboembolism in patients with high risk of bleeding hospitalized in intensive care units: the CIREA1 randomized trial. Intensive Care Medicine. 2013;39:872-880.
Boyarintsev VV, Alencheva EV, Lobastov KV, Barinov VE. Possibilities and prospects of intermittent pneumatic compression as a part of complex prevention of postoperative venous thromboembolic complications. Kremlevskaya Meditsina. Klinicheskiy Vestnik. 2016;2:12-19. (In Russ.)
Zhao JM, He ML, Xiao ZM, Li TS, Wu H, Jiang H. Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement. The Cochrane Database of Systematic Reviews. 2014;12:CD009543. https://doi.org/10.1002/14651858.CD009543.pub3
Pavon JM, Adam SS, Razouki ZA, McDuffie JR, Lachiewicz PF, Kosinski AS, Beadles CA, Ortel TL, Nagi A, Williams JW Jr. Effectiveness of Intermittent Pneumatic Compression Devices for Venous Thromboembolism Prophylaxis in High-Risk Surgical and Medical Patients: A Systematic Review. The Journal of Arthroplasty. 2015;31(2):524-532. https://doi.org/10.1016/j.arth.2015.09.043
Lash GE, Otun HA, Innes BA, Bulmer JN, Searle RF, Robson SC. Low oxygen concentrations inhibit trophoblast cell invasion from early gestation placental explants via alterations in levels of the urokinase plasminogen activator system. Biology of Reproduction. 2006;74:403-409. https://doi.org/10.1095/biolreprod.105.047332
Soares MJ, Chakraborty D, Kubota K, Renaud SJ, Rumi MA. Adaptive mechanisms controlling uterine spiral artery remodeling during the establishment of pregnancy. International Journal of Developmental Biology. 2014;58:247-259. https://doi.org/10.1387/ijdb.140083ms
Sidelnikova VM. Podgotovka i vedenie beremennosti u zhenshchin s privychnym nevynashivaniem. Metodicheskie posobiya i klinicheskie protokoly. 3-e izdanie. M.: MEDpress-inform, 2013. (In Russ.)
Brosens I, Pijnenborg R, Vercruysse L, Romero R. The «Great Obstetrical Syndromes» are associated with disorders of deep placentation. American Journal of Obstetrics and Gynecology. 2011;204(3):193-201. https://doi.org/10.1016/j.ajog.2010.08.009
Yao Y, Aurelia VI, Xi Zhang, Junyan Zhu, Thaler CJ, Mahner S, Udo J, von Schönfeldt V. Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases. International Journal of Molecular Sciences. 2017;18(8):1651. https://doi.org/10.3390/ijms18081651
Gris JC, Ripart-Neveu S, Maugard C, Tailland ML, Brun S, Courtieu C, Biron C, Hoffet M, Hedon B, Mares P. Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study. Thrombosis and Haemostasis. 1997;77:1096-1103.
Ishutina EYu. Sostoyanie fibrinoliticheskoj sistemy krovi v pervom trimestre beremennosti u zhenshchin s privychnym nevynashivaniem: Avtoref. dis. … kand.med. nauk.CPb;2004. (In Russ.)
Bodova KB, Biringer K, Dokus K, Ivankova J, Stasko J, Danko J. Fibronectin, plasminogen activator inhibitor type 1 (PAI-1) and uterine artery Doppler velocimetry as markers of preeclampsia. Disease Markers.
;30(4):191-196. https://doi.org/10.1155/2011/219350
Wikstrom AK, Nash P, Eriksson UJ, Olovsson MH. Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia. American Journal of Obstetrics and Gynecology. 2009; 201:597. https://doi.org/10.1016/j.ajog.2009.06.024
Catarino C, Rebelo I, Belo L, Rocha S, Castro EB, Patricio B, Quintanilha A, Santos-Silva A. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies. Thrombosis Research. 2008;123:219-224. https://doi.org/10.1016/j.thromres.2008.02.007
Martínez-Zamora MA, Creus M, Tassies D, Reverter JC, Civico S, Carmona F, Balasch J. Reduced plasma fibrinolytic potential in patients with recurrent implantation failure after IVF and embryo transfer. Human Reproduction. 2011;26(3):510-516. https://doi.org/10.1093/humrep/deq369
Momot AP, Tsyvkina LP, lydina IV, Borisova OG. Ways of progress in improving the results of in vitro fertilization based on the detection and correction of hemostatic pathology (I). Tromboz, Hemostaz i Reologiya. 2013;1:5-17. (In Russ.)
Momot AP, Molchanova IV, Tsyvkina LP, lydina IV, Borisova OG. Ways of progress in improving the results of in vitro fertilization based on the detection and correction of hemostatic pathology (II). Tromboz, Hemostaz i Reologiya. 2013;2:6-23. (In Russ.)
Momot AP, Lydina IV, Borisova OG, Elykomov VA, Tsyvkina LP. In vitro fertilization and the control of hemostasis. Problemy Reproduktsii. 2012;18(6):47-55. (In Russ.)
Momot AP, Tomilina OP, Molchanova IV, Shipulina VG, Tsyvkina LP, Serdyuk GV. The importance of therapeutic correction of hemostatic and fibrinolytic disorders for the in vitro fertilization outcomes and early reproductive losses. Hemorragicheskiye Diathezy, Trombozy, Trombofilii. 2014;1:58-61. (In Russ.)